Romania
· Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 3.49 billion. The enterprise value is 5.17 billion.
| Market Cap | 3.49B |
| Enterprise Value | 5.17B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.91 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 530.91M |
| Shares Outstanding | 530.91M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 39.27% |
| Owned by Institutions (%) | 26.35% |
| Float | 322.44M |
Valuation Ratios
The trailing PE ratio is 146.30 and the forward PE ratio is 43.15.
| PE Ratio | 146.30 |
| Forward PE | 43.15 |
| PS Ratio | 1.22 |
| PB Ratio | 6.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 227.42 |
| P/OCF Ratio | 12.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.56, with an EV/FCF ratio of 336.73.
| EV / Earnings | 215.96 |
| EV / Sales | 1.81 |
| EV / EBITDA | 12.56 |
| EV / EBIT | 35.67 |
| EV / FCF | 336.73 |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of 3.40.
| Current Ratio | 0.69 |
| Quick Ratio | 0.47 |
| Debt / Equity | 3.40 |
| Debt / EBITDA | 4.25 |
| Debt / FCF | 113.97 |
| Interest Coverage | 1.53 |
Financial Efficiency
Return on equity (ROE) is 2.78% and return on invested capital (ROIC) is 4.16%.
| Return on Equity (ROE) | 2.78% |
| Return on Assets (ROA) | 3.11% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 6.92% |
| Revenue Per Employee | 445,225 |
| Profits Per Employee | 3,735 |
| Employee Count | 6,638 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 11.03 |
Taxes
In the past 12 months, Med Life has paid 23.36 million in taxes.
| Income Tax | 23.36M |
| Effective Tax Rate | 62.18% |
Stock Price Statistics
The stock price has increased by +4.32% in the last 52 weeks. The beta is 0.64, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +4.32% |
| 50-Day Moving Average | 6.37 |
| 200-Day Moving Average | 6.06 |
| Relative Strength Index (RSI) | 47.19 |
| Average Volume (20 Days) | 169,286 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 2.86 billion and earned 23.95 million in profits. Earnings per share was 0.04.
| Revenue | 2.86B |
| Gross Profit | 1.39B |
| Operating Income | 145.03M |
| Pretax Income | 37.57M |
| Net Income | 23.95M |
| EBITDA | 320.57M |
| EBIT | 145.03M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 141.21 million in cash and 1.75 billion in debt, giving a net cash position of -1.61 billion or -3.03 per share.
| Cash & Cash Equivalents | 141.21M |
| Total Debt | 1.75B |
| Net Cash | -1.61B |
| Net Cash Per Share | -3.03 |
| Equity (Book Value) | 514.78M |
| Book Value Per Share | 0.84 |
| Working Capital | -304.87M |
Cash Flow
In the last 12 months, operating cash flow was 270.35 million and capital expenditures -254.99 million, giving a free cash flow of 15.36 million.
| Operating Cash Flow | 270.35M |
| Capital Expenditures | -254.99M |
| Free Cash Flow | 15.36M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 48.78%, with operating and profit margins of 5.08% and 0.84%.
| Gross Margin | 48.78% |
| Operating Margin | 5.08% |
| Pretax Margin | 1.32% |
| Profit Margin | 0.84% |
| EBITDA Margin | 11.23% |
| EBIT Margin | 5.08% |
| FCF Margin | 0.54% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.69% |
| FCF Yield | 0.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.7 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.7 |
| Piotroski F-Score | 6 |